| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Hungary | 2 | |
| #7 | Slovenia | 2 | |
| #8 | United States | 2 | |
| #9 | EAPO (Eurasian Patent Organization) | 1 | |
| #10 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Grosse-Hovest Ludger | 15 |
| #2 | Jung Gundram | 9 |
| #3 | Aulwurm Steffen | 8 |
| #4 | Durben Michael | 8 |
| #5 | Hofmann Martin | 7 |
| #6 | Jung Grundram | 7 |
| #7 | Buehring Hans-Joerg | 5 |
| #8 | Ludger Grosse-Hovest | 3 |
| #9 | Martin Hofmann | 2 |
| #10 | Grundram Jung | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CN110856751A | Therapeutic agents comprising nucleic acids and TCR-modified immune cells and uses thereof | |
| WO2013092001A1 | Bispecific antibody molecule | |
| WO2011089211A1 | Anti-cd133 antibodies and methods of using the same | |
| CA2785178A1 | Anti-flt3 antibodies and methods of using the same |